BRCTF
Price
$34.29
Change
+$2.91 (+9.27%)
Updated
Oct 2 closing price
Capitalization
2.96B
SNDX
Price
$15.60
Change
+$0.16 (+1.04%)
Updated
Oct 3 closing price
Capitalization
1.34B
36 days until earnings call
Interact to see
Advertisement

BRCTF vs SNDX

Header iconBRCTF vs SNDX Comparison
Open Charts BRCTF vs SNDXBanner chart's image
BIOARCTIC AB
Price$34.29
Change+$2.91 (+9.27%)
Volume$240
Capitalization2.96B
Syndax Pharmaceuticals
Price$15.60
Change+$0.16 (+1.04%)
Volume$1.78M
Capitalization1.34B
BRCTF vs SNDX Comparison Chart in %
BRCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRCTF vs. SNDX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRCTF is a StrongBuy and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (BRCTF: $34.29 vs. SNDX: $15.60)
Brand notoriety: BRCTF and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRCTF: 81% vs. SNDX: 74%
Market capitalization -- BRCTF: $2.96B vs. SNDX: $1.34B
BRCTF [@Biotechnology] is valued at $2.96B. SNDX’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRCTF’s FA Score shows that 2 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • BRCTF’s FA Score: 2 green, 3 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, BRCTF is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRCTF’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • BRCTF’s TA Score: 3 bullish, 4 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BRCTF and SNDX are a bad buy in the short-term.

Price Growth

BRCTF (@Biotechnology) experienced а +9.28% price change this week, while SNDX (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

SNDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRCTF($2.96B) has a higher market cap than SNDX($1.34B). BRCTF YTD gains are higher at: 87.362 vs. SNDX (18.003). BRCTF has higher annual earnings (EBITDA): 1.2B vs. SNDX (-314.25M). BRCTF has more cash in the bank: 1.92B vs. SNDX (469M). SNDX has less debt than BRCTF: SNDX (1.68M) vs BRCTF (49M). BRCTF has higher revenues than SNDX: BRCTF (1.86B) vs SNDX (77.9M).
BRCTFSNDXBRCTF / SNDX
Capitalization2.96B1.34B220%
EBITDA1.2B-314.25M-383%
Gain YTD87.36218.003485%
P/E Ratio26.83N/A-
Revenue1.86B77.9M2,388%
Total Cash1.92B469M409%
Total Debt49M1.68M2,925%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRCTFSNDX
RSI
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
59%
Bearish Trend 6 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
37%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BRCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAAIX10.460.10
+0.97%
Altegris/AACA Opportunistic Real Estt I
LMASX36.900.34
+0.93%
ClearBridge Small Cap C
HNSGX15.410.05
+0.33%
Harbor Small Cap Growth Retirement
JEMOX40.980.12
+0.29%
JPMorgan Emerging Markets Equity R5
ADNPX23.17-0.11
-0.47%
American Beacon ARK Transfmt Innov Inv

BRCTF and

Correlation & Price change

A.I.dvisor tells us that BRCTF and CGTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BRCTF and CGTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRCTF
1D Price
Change %
BRCTF100%
N/A
CGTX - BRCTF
28%
Poorly correlated
+8.39%
RLAY - BRCTF
25%
Poorly correlated
+4.98%
SNDX - BRCTF
22%
Poorly correlated
+1.04%
PHGUF - BRCTF
22%
Poorly correlated
N/A
GRI - BRCTF
21%
Poorly correlated
-3.05%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.04%
REPL - SNDX
51%
Loosely correlated
+1.72%
CGON - SNDX
50%
Loosely correlated
-0.09%
NUVL - SNDX
48%
Loosely correlated
+0.43%
NRIX - SNDX
48%
Loosely correlated
+3.30%
IDYA - SNDX
47%
Loosely correlated
+1.62%
More